BeOne Medicines AG (HKG:6160)

Hong Kong · Delayed Price · Currency is HKD

185.70

+1.90 (1.03%)

Nov 5, 2025, 2:45 PM HKT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2020
U.S. Revenue	2.39B	1.96B	Log In	Log In	Log In	Upgrade
China Revenue	1.57B	1.41B	Log In	Log In	Log In	Upgrade
Europe Revenue	484.32M	362.63M	Log In	Log In	Log In	Upgrade
Rest of World Revenue	120.06M	78.81M	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2012 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2012 - 2020
BRUKINSA Revenue	3.26B	2.64B	Log In	Log In	Log In	Upgrade
Tislelizumab Revenue	681.84M	620.84M	Log In	Log In	Log In	Upgrade
XGEVA Revenue	277.71M	224.40M	Log In	Log In	Log In	Upgrade
BLINCYTO Revenue	90.33M	74.33M	Log In	Log In	Log In	Upgrade
KYPROLIS Revenue	75.27M	66.17M	Log In	Log In	Log In	Upgrade
POBEVCY Revenue	50.29M	53.51M	Log In	Log In	Log In	Upgrade
REVLIMID Revenue	-	36.03M	Log In	Log In	Log In	Upgrade
VIDAZA Revenue	-	-	Log In	Log In	Log In	Upgrade
Pamiparib Revenue	-	-	Log In	Log In	Log In	Upgrade
Other Product Revenue	-	60.04M	Log In	Log In	Log In	Upgrade
Total Other Product Revenue	86.84M	96.07M	Log In	Log In	Log In	Upgrade
Total Product Revenue	4.52B	3.78B	Log In	Log In	Log In	Upgrade
Collaboration Revenue	39.91M	30.70M	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.